Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip™ Device
ABBOTT PARK, Ill.,
"MitraClip is a first-of-its-kind, life-saving device that has transformed the lives of more than 100,000 people living with leaky mitral valves, many of whom were not treatable with open-heart mitral valve surgery – leaving them with few to no options," said
The Prix Galien award for MitraClip is one of several recent recognitions for Abbott:
- Abbott's newest rapid COVID-19 test, BinaxNOW™ COVID-19
Ag Card , was recognized as a top innovation by the Chicago Innovation Awards and Abbott's ID NOW™ COVID-19 rapid molecular test was recognized by ChicagoInno as a 2020 Inno on Fire winner. - Abbott's smaller-than-a-pea, innovative device, Amplatzer Piccolo™ Occluder, which treats preemie and newborn babies with an opening in their hearts, received an Edison Award for its human-centered design in prenatal and infant care, and was also recognized in the R&D 100 Awards, which highlights the most prestigious innovations and revolutionary advancements in science and technology.
- Abbott was recognized as
Fast Company's "World Changing Company of the Year" for its Piccolo innovation, its work advancing the careers of underrepresented people in STEM, initiatives to fight malaria around the world, and for the company's COVID-19 tests. - Abbott was also named to Fortune's 2020 "Change the World" list for expanding access to quality primary care and diagnostic testing in
Rwanda , and for advancing innovative testing to confront the COVID-19 pandemic.
About MitraClip:
Backed by more than 16 years of clinical experience and proven safety, effectiveness and durability of clinical outcomes, MitraClip is a small, clip-like device that repairs both primary and secondary mitral regurgitation (MR) without the need for open-heart surgery. The proven safe, minimally invasive procedure restores proper functioning of the mitral valve and provides almost immediate symptom relief. MitraClip patients are generally discharged from the hospital within two days, allowing them to return to their regular lives much faster than open-heart surgery. MitraClip is approved in more than 75 countries worldwide, spanning regions in
For more information on MitraClip, visit: www.structuralheartsolutions.com.
For
For
For
ID NOW COVID-19 and BinaxNOW COVID-19
About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.
Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.
1 Data on file,
View original content:http://www.prnewswire.com/news-releases/abbott-wins-prestigious-prix-galien-usa-award-for-first-of-its-kind-mitraclip-device-301163728.html
SOURCE Abbott
Abbott Media, Mary Kokkinen, (408) 444-2401; or Abbott Financial, Mike Comilla, (224) 668-1872